← Back to all substances
C

warfarin

135ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction...

Known as: Warfarin Sodium
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
132,198
Total in FDA
84%
Serious Reports
58
Fatal Outcomes

Seriousness

Serious
422
Non-Serious
78

Sex Distribution

Male
236
Female
249
Unknown
15

Age Distribution

0-17
4
18-40
21
41-64
138
65-84
238
85+
36
Unknown
63

Outcomes

Recovered/Resolved
305
Recovering/Resolving
157
Not Recovered/Not Resolved
103
Recovered with Sequelae
5
Fatal
58
Unknown
706

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-33035a
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...